Literature DB >> 15997884

Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors.

C I Mboto1, A Davies-Russell, M Fielder, A P Jewell.   

Abstract

This study evaluates the seroprevalence and risk factors for hepatitis C (HCV) antibodies in asymptomatic first-time blood donors in The Gambia. The study population includes 460 blood donors (age range: 18-40 years [mean: 27.5]) who attended the Royal Victoria Teaching Hospital from July to December 2002. Antibodies to hepatitis C are determined using and enzyme-linked immunosorbent assay (ELISA) test system. The prevalence of hepatitis C found in this study was 1.1% (95% CI, 0.16-1.12). Previous history of sexually transmitted disease, married men in polygamous relationships, and hospital or clinic-based workers were determined to be at risk of acquiring hepatitis C. The study shows that seroprevalence of hepatitis C in The Gambia is low compared to other countries in the region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997884     DOI: 10.1080/09674845.2005.11732692

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  3 in total

1.  Prevalence, sociodemographic characteristics and risk factors for hepatitis C infection among pregnant women in Calabar municipality, Nigeria.

Authors:  Clement Ibi Mboto; Iniobong Ebenge Andy; Ogban Ibor Eni; Andrew Paul Jewell
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

2.  Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.

Authors:  Thomas J Peto; Maimuma E Mendy; Yamundow Lowe; Emily L Webb; Hilton C Whittle; Andrew J Hall
Journal:  BMC Infect Dis       Date:  2014-01-07       Impact factor: 3.090

3.  Implementing a Birth Dose of Hepatitis B Vaccine in Africa: Findings from Assessments in 5 Countries.

Authors:  Edna Moturi; Carole Tevi-Benissan; José E Hagan; Stephanie Shendale; David Mayenga; Daniel Murokora; Minal Patel; Karen Hennessey; Richard Mihigo
Journal:  J Immunol Sci       Date:  2018-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.